Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 47

Results For "CRO"

5783 News Found

Aster DM Healthcare PAT at Rs 44.47 crores for Q1FY22
News | August 12, 2021

Aster DM Healthcare PAT at Rs 44.47 crores for Q1FY22

Income declines marginally


Natco Pharma PAT at Rs 75 crore for Q1FY22
News | August 12, 2021

Natco Pharma PAT at Rs 75 crore for Q1FY22

The company has strong product launches both in India and overseas


AstraZeneca Pharma India PAT at Rs 10.24 crores
Biotech | August 09, 2021

AstraZeneca Pharma India PAT at Rs 10.24 crores

Board declares interim dividend of Rs 2 per equity share


Centre releases Rs. 60 crore to states seeking grants to tackle the Sickle Cell Anaemia
Policy | August 09, 2021

Centre releases Rs. 60 crore to states seeking grants to tackle the Sickle Cell Anaemia

Sickle Cell Disease Support Corner developed to create a database of individuals with sickle cell disease


Metropolis Healthcare PAT at Rs 74.89 crores for Q1FY22
Healthcare | August 08, 2021

Metropolis Healthcare PAT at Rs 74.89 crores for Q1FY22

Board approves fundraise of Rs 1500 crore


Divi's Labs posts a 13 per cent rise in PAT at Rs 557.11 crore
News | August 08, 2021

Divi's Labs posts a 13 per cent rise in PAT at Rs 557.11 crore

Forex gains stood at Rs 20 crore for the quarter


Alkem Laboratories PAT at Rs 468.12 crore for Q1FY22
News | August 08, 2021

Alkem Laboratories PAT at Rs 468.12 crore for Q1FY22

EPS stood at Rs 39.15


Cipla posts  net profit at Rs 715 crores
News | August 08, 2021

Cipla posts net profit at Rs 715 crores

India business contributes to a stellar performance


Solara Active Pharma Science clocks net profit of Rs 50.13 crore in Q1FY22
News | August 04, 2021

Solara Active Pharma Science clocks net profit of Rs 50.13 crore in Q1FY22

Aditya Puri former MD of HDFC bank joins Solara board as chairman


Nureca Ltd PAT at Rs 36.19 crore in Q1FY22
Healthcare | August 03, 2021

Nureca Ltd PAT at Rs 36.19 crore in Q1FY22

Nureca Ltd has reported financial results for the period ended June 30, 2021.